Correction to: Protease-stable DARPins as promising oral therapeutics
Protein Eng Des Sel
.
2022 Feb 17:35:gzac003.
doi: 10.1093/protein/gzac003.
Authors
Rudo A Simeon
1
,
Yu Zeng
1
,
Vikas Chonira
1
,
Andrea Martinez Aguirre
2
,
Mauricio Lasagna
3
,
Marko Baloh
2
,
Joseph A Sorg
2
,
Cecilia Tommos
3
,
Zhilei Chen
1
Affiliations
1
Department of Microbial Pathogenesis and Immunology, Texas A&M University Health Science Center, 8847 Riverside Pkwy, Bryan, TX 77807, USA.
2
Department of Biology, Texas A&M University, 424 Nagle St, College Station, TX 77840, USA.
3
Department of Biochemistry and Biophysics, Texas A&M University, 300 Olsen Blvd, College Station, TX 77843, USA.
PMID:
35368085
PMCID:
PMC9081868
DOI:
10.1093/protein/gzac003
No abstract available
Publication types
Published Erratum
Grants and funding
R01 GM079190/GM/NIGMS NIH HHS/United States
R01GM079190/NH/NIH HHS/United States